(Q34576143)

3 August 2017

title

Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury (English)

1 reference

3 August 2017

0 references

1 reference

J F Eidt

1

1 reference

3 August 2017

P Allison

2

1 reference

3 August 2017

S Noble

3

1 reference

3 August 2017

J Ashton

4

1 reference

3 August 2017

P Golino

5

1 reference

3 August 2017

J McNatt

6

1 reference

3 August 2017

L M Buja

7

1 reference

3 August 2017

J T Willerson

8

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 July 1989

1 reference

Journal of Clinical Investigation

3 August 2017

published in

1 reference

3 August 2017

volume

84

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

18-27

1 reference

PLATELET SEQUESTRATION IN MAN. I. METHODS.

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

A comparison of the antithrombotic and haemorrhagic effects of low molecular weight heparin fractions: the influence of the method of preparation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Platelet active concentration profiles near growing thrombi. A mathematical consideration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

A new thrombin inhibitor MD805 and thrombocytopenia encountered with heparin hemodialysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Responses of aortic smooth muscle to thrombin and thrombin analogues

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Effect of heparin and low molecular weight heparins on thrombin-induced blood platelet activation in the absence of antithrombin III.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

The measurement of thrombin in clotting blood by radioimmunoassay

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Molecular weight determination of commercial heparin sodium USP and its sterile solutions

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

The effect of heparin on factor XIa and plasmin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Actions and Interactions of Antithrombin and Heparin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

A tanned red cell hemagglutination inhibition immunoassay (TRCHII) for the quantitative estimation of thrombin-antithrombin III and plasmin-alpha1-antiplasmin complexes in human plasma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Heparin cofactor activity measured with an amidolytic method

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Mechanisms of Unstable Angina

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=303947

Conversion from chronic to acute coronary artery disease: Speculation regarding mechanisms

9 December 2018

1 reference

12 December 2020

Inhibition of bovine factor IXa and factor Xa.beta. by antithrombin III

1 reference

12 December 2020

Synchronized pulsed Doppler blood flow and ultrasonic dimension measurement in conscious dogs

1 reference

12 December 2020

Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease

1 reference

12 December 2020

Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion

1 reference

12 December 2020

Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?

1 reference

12 December 2020

Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation

1 reference

12 December 2020

Platelet-leukocyte interaction: selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes, and related cell lines

1 reference

12 December 2020

Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuit

1 reference

12 December 2020

Inhibition of thrombin-catalyzed reactions in blood coagulation and platelet activation by heparin fractions in the absence of antithrombin III

1 reference

12 December 2020

Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes

1 reference

12 December 2020

Platelet activation in unstable coronary disease

1 reference

12 December 2020

Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect

1 reference

12 December 2020

Lack of relationship between enhanced bleeding induced by heparin and other sulfated polysaccharides and enhanced catalysis of thrombin inhibition

1 reference

12 December 2020

Platelet activation by alpha-thrombin is a receptor-mediated event

1 reference

12 December 2020

Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals

1 reference

12 December 2020

Production in vitro and properties of a modified form of bovine antithrombin, cleaved at the active site by thrombin

1 reference

12 December 2020

Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist

1 reference

12 December 2020

High molecular weight forms of antithrombin III complexes in blood

1 reference

12 December 2020

Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets

1 reference

12 December 2020

Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid

1 reference

12 December 2020

Characterization of the thrombin-induced contraction of vascular smooth muscle

1 reference

12 December 2020

Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries

1 reference

12 December 2020

Structure of heparins and their fragments

1 reference

12 December 2020

Effect of heparin on platelet aggregation

1 reference

12 December 2020

The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries

1 reference

12 December 2020

Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI114138

1 reference

3 August 2017

1 reference

3 August 2017

1 reference